$Acurx Pharmaceuticals(ACXP.US)$Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development
$Acurx Pharmaceuticals(ACXP.US)$Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients 2 MINUTES AGO, 7:00 AM EST VIA PR NEWSWIRE
$Acurx Pharmaceuticals(ACXP.US)$Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients 4 MINUTES AGO, 7:01 AM EST VIA PR NEWSWIRE
$Acurx Pharmaceuticals(ACXP.US)$Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure
Acurx Pharmaceuticals股票討論區
Like! Update
Dow Jones· 7 mins ago
Update
Update
2 MINUTES AGO, 7:00 AM EST
VIA PR NEWSWIRE
up
Update
4 MINUTES AGO, 7:01 AM EST
VIA PR NEWSWIRE
Update
暫無評論